Sign Up to like & get
recommendations!
0
Published in 2024 at "European Psychiatry"
DOI: 10.1007/s40501-024-00331-y
Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for managing metabolic disorders such as type 2 diabetes mellitus (T2DM) and obesity. Beyond their metabolic benefits, GLP-1 RAs exhibit neuroprotective and psychotropic effects, potentially benefiting…
read more here.
Keywords:
glp ras;
mental health;
ras mental;
systematic review ... See more keywords